Personalized dietary guidance powered by your patient's genetics, lab values, and active medications — surfaced directly in your EHR workflow.
1 in 3 Alaska Native adults has Type 2 diabetes. Nutrition is the primary intervention — but no provider has time to cross-reference a patient's genomic variants, lab values, and active medications to give individualized food guidance. Until now.
CareShield reads what the EHR already knows, adds what genetics reveal, and delivers a ranked, actionable nutrition plan — without disrupting the clinical workflow.
One-tap OAuth via SMART on FHIR. CareShield reads conditions, active medications, and lab values directly from Cerner, Epic, or any IHS-connected system. No manual data entry.
Raw 23andMe file or clinical whole-genome data. CareShield extracts 11+ metabolic SNPs — MTHFR, APOE, FADS1, TCF7L2, PNPLA3 (NAFLD risk), HFE, FUT2, and more.
A nutrition intelligence panel surfaces inside the EHR workflow. Drug–nutrient–gene crossovers are flagged. Foods ranked by clinical priority. One screen. Built for a 15-minute visit.
CareShield is not a whitepaper. The core infrastructure is deployed, tested, and loading real patient data from the Cerner R4 FHIR API.
Full OAuth 2.0 PKCE launch from Cerner EHR. Reads conditions, medications, labs, and patient demographics.
LiveMTHFR C677T/A1298C, APOE ε4, FADS1, TCF7L2, PNPLA3 (NAFLD), HFE, FUT2, CYP1A2, FTO, ALDH2.
LiveAutomatically flags when a medication depletes a nutrient that a genomic variant also impairs. Surfaced as a single actionable insight.
LiveCareShield MPage launches inside the Cerner workflow. No new login, no context switching. The nutrition panel is part of the chart.
LivePNPLA3 rs738409, TCF7L2 rs7903146, and HFE C282Y directly target the T2DM-to-NAFLD disease spectrum prevalent in Native populations.
Proof of ConceptCloudflare Workers + D1 — zero patient data at rest in cloud AI systems. HIPAA-ready architecture. Data sovereignty by design.
LiveIHS and tribal health systems carry the highest burden of metabolic disease and have the fewest tools for individualized nutrition intervention. CareShield is designed for this gap.
Tribal health systems and IHS-affiliated facilities in Alaska carry the highest per-capita burden of metabolic liver disease in the country. CareShield is designed around their clinical workflows and patient populations.
Urban Native American communities represent a distinct and underserved population with high rates of T2DM and NAFLD. Expanding the study beyond Alaska into pan-tribal urban settings is a core research goal.
600+ IHS-operated and tribally operated facilities nationwide. CareShield's Cerner SMART integration targets the Cerner EHR deployments that serve the majority of IHS facilities.
Insulin resistance, metabolic syndrome, non-alcoholic fatty liver disease, and liver fibrosis share the same upstream nutrition drivers. CareShield targets the continuum, not just the diagnosis.
Janus NW Research LLC is a majority Native-founded company registered in Alaska.
Biology senior, University of Missouri–Kansas City. Majority owner and company PI for the NIH STTR R41 application. Brings academic biology foundation and patient-centered perspective to CareShield's clinical research design.
Software engineer with 15+ years of systems and infrastructure experience. Designed and built the CareShield FHIR stack, self-hosted AI infrastructure, and the genomic nutrition intelligence engine on Cloudflare Workers + D1.
NIH STTR R41 submission in progress. Pre-seed conversations welcome from investors who understand healthcare infrastructure and health equity.
We are not seeking a valuation conversation yet. We want the right partners — people who understand health disparities, FHIR infrastructure, or tribal health systems.